AJANTA PHARMA LTD.
Market Cap.(`)
|
30194.81 Cr.
|
P/BV
|
8.46
|
Book Value (`)
|
283.30
|
52 Week High/Low ( ` )
|
2540/1247
|
FV/ML
|
2/1
|
P/E(X)
|
37.00
|
Book Closure
|
08/02/2024
|
EPS (`)
|
64.82
|
Div Yield (%)
|
2.13
|
You can view the
Consolidated
Ratio Analysis
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 64.82 | 45.89 | 82.45 | 75.09 | 53.60 |
Diluted EPS (Rs.) | 64.77 | 45.89 | 82.45 | 75.09 | 53.60 |
Cash EPS (Rs.) | 75.31 | 56.89 | 97.61 | 88.55 | 64.24 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 282.34 | 268.14 | 380.24 | 344.52 | 296.34 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 282.34 | 268.14 | 380.24 | 344.52 | 296.34 |
Revenue From Operations / Share (Rs.) | 333.10 | 296.21 | 389.17 | 332.34 | 295.08 |
PBDIT / Share (Rs.) | 99.45 | 69.80 | 121.72 | 117.83 | 88.43 |
PBIT / Share (Rs.) | 88.73 | 59.45 | 107.13 | 104.48 | 77.51 |
PBT / Share (Rs.) | 88.16 | 58.98 | 105.94 | 103.53 | 75.71 |
Net Profit / Share (Rs.) | 64.60 | 46.54 | 83.01 | 75.20 | 53.33 |
NP After MI And SOA / Share (Rs.) | 64.60 | 46.54 | 83.01 | 75.20 | 53.33 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 29.85 | 23.56 | 31.27 | 35.45 | 29.96 |
PBIT Margin (%) | 26.63 | 20.06 | 27.52 | 31.43 | 26.26 |
PBT Margin (%) | 26.46 | 19.91 | 27.22 | 31.15 | 25.65 |
Net Profit Margin (%) | 19.39 | 15.71 | 21.33 | 22.62 | 18.07 |
NP After MI And SOA Margin (%) | 19.39 | 15.71 | 21.33 | 22.62 | 18.07 |
Return on Networth / Equity (%) | 22.87 | 17.35 | 21.83 | 21.82 | 17.99 |
Return on Capital Employeed (%) | 29.95 | 21.21 | 26.98 | 29.02 | 25.06 |
Return On Assets (%) | 17.59 | 12.56 | 17.57 | 17.30 | 14.09 |
Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Asset Turnover Ratio (%) | 0.90 | 0.81 | 0.83 | 0.79 | 0.76 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 3.05 | 2.49 | 3.50 | 3.13 | 2.71 |
Quick Ratio (X) | 2.12 | 1.77 | 2.28 | 1.94 | 1.89 |
Inventory Turnover Ratio (X) | 1.14 | 1.19 | 1.10 | 1.25 | 1.28 |
Dividend Payout Ratio (NP) (%) | 0.00 | 15.25 | 11.53 | 12.67 | 24.25 |
Dividend Payout Ratio (CP) (%) | 0.00 | 12.47 | 9.81 | 10.76 | 20.13 |
Earning Retention Ratio (%) | 0.00 | 84.75 | 88.47 | 87.33 | 75.75 |
Cash Earning Retention Ratio (%) | 0.00 | 87.53 | 90.19 | 89.24 | 79.87 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 174.28 | 151.01 | 102.45 | 123.89 | 65.11 |
Interest Coverage Ratio (Post Tax) (%) | 114.20 | 101.68 | 70.87 | 80.07 | 40.60 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 28149.11 | 14945.61 | 15321.67 | 15384.30 | 11819.91 |
EV / Net Operating Revenue (X) | 6.69 | 3.99 | 4.59 | 5.32 | 4.57 |
EV / EBITDA (X) | 22.40 | 16.95 | 14.66 | 15.02 | 15.24 |
MarketCap / Net Operating Revenue (X) | 6.72 | 4.08 | 4.65 | 5.40 | 4.63 |
Retention Ratios (%) | 0.00 | 84.74 | 88.46 | 87.32 | 75.74 |
Price / BV (X) | 7.93 | 4.51 | 4.76 | 5.21 | 4.61 |
Price / Net Operating Revenue (X) | 6.72 | 4.08 | 4.65 | 5.40 | 4.63 |
EarningsYield | 0.02 | 0.03 | 0.04 | 0.04 | 0.03 |